Shanghvi's Silent 'Sun' Rise
Acquisitions and product focus make Shanghvi India's wealthiest drug maker.
ranbaxy
September 2022
September 2018
January 2011
Shivinder drags brother Malvinder to NCLT
Former Ranbaxy promoter dissociates with brother; case also names former Religare chief Godhwani.
Daiichi overhauls Ranbaxy
The Indianness of the homegrown pharma major is slowly but surely being diluted by its new Japanese owners. Not without its fair share of obstacles, though.
